Physician profile
Thomas E Heineman
NPI 1881089704
$373,128.20
in general payments reported to CMS, 2019-2025
9 companies · $100K in 2025
The $100K reported for 2025 was more than what 99% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $905 · 2021: $975 · 2022: $47K · 2023: $95K · 2024: $129K · 2025: $100K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $259K · Travel and Lodging: $31K · Honoraria: $28K · Food and Beverage: $5,838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $259,443.75 |
| Travel and Lodging | $31,076.70 |
| Honoraria | $28,000.00 |
| Food and Beverage | $5,838.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $294,078.05 | 2020-2025 | Inspire |
| Siesta Medical, INC. | $60,900.00 | 2022-2025 | |
| Aerin Medical INC. | $15,426.04 | 2024-2025 | |
| Stryker Corporation | $2,590.10 | 2020-2025 | Scopis Ent, Audion Et Dilation System |
| Zoll Respicardia, INC. | $50.25 | 2024 | Remede System |
| Karl Storz Endoscopy-America | $33.07 | 2022 | |
| Pfizer INC. | $23.18 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $14.77 | 2025 | Neffy |
| Biohaven Pharmaceutical Holding Company Ltd. | $12.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Heineman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.